Portola Pharma Investors Ink $17.5M Deal Over Stock Declines
Investors in biotechnology company Portola Pharmaceuticals Inc. have asked a San Francisco federal judge to give an initial nod to a $17.5 million deal that would end claims the company failed...To view the full article, register now.
Already a subscriber? Click here to view full article